1993
DOI: 10.1016/0738-081x(93)90163-7
|View full text |Cite
|
Sign up to set email alerts
|

Pustular drug reactions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

1999
1999
2017
2017

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 28 publications
0
8
0
Order By: Relevance
“…Lesions usually develop at malar, postauricular, axillary, and genital regions, but may extend further [43]. Chloracne treatment is challenging and the lesions may continue developing for a long time, despite avoiding exposure to chloracnegens [44].…”
Section: Chlorinementioning
confidence: 99%
“…Lesions usually develop at malar, postauricular, axillary, and genital regions, but may extend further [43]. Chloracne treatment is challenging and the lesions may continue developing for a long time, despite avoiding exposure to chloracnegens [44].…”
Section: Chlorinementioning
confidence: 99%
“…Thalidomide has been used in a few cases to prevent relapses of recurrent EM. [19] Other drugs which have been [6] Erythroderma/ exfoliative dermatitis [7] Urticaria/ anaphylaxis [8] Pigmentation [9] Acute generalized exanthematous pustulosis [10,11] Pemphigus [12] Vasculitis [13] Ampicillin…”
Section: Managementmentioning
confidence: 99%
“…The precipitation or exacerbation of pustular psoriasis by lithium is well documented. 38,42,115 The other pustular eruptions reported with lithium therapy are palmoplantar pustulosis, 43 linear immunoglobulin A (IgA) bullous dermatosis, 116 and subcorneal pustular dermatosis (Sneddon-Wilkinson disease). 117 The pathogenesis involves the action of lithium on neutrophilic chemotaxis and the release of lysosomal enzymes, coupled with its effects on adenyl cyclase and inositol-mediated pathways.…”
Section: Papulosquamous Dermatosesmentioning
confidence: 99%